Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: Is in-hospital admission absolutely necessary?

PACE - Pacing and Clinical Electrophysiology

Volumn 19, Issue 11 II, 1996, Pages 1939-1943

  Botto, G L ^a   Bonini, W ^a   Broffoni, T ^a   Molteni, S ^a   Lombardi, R ^a   Alfieri, G ^a   Barone, P ^a   Bernasconi, G ^a   Ferrari, G ^a  

^a SANT ANNA HOSPITAL   (Italy)

Author keywords

atrial fibrillation; bradyarrhythmia; hospitalization; proarrhythmia; propafenone

Indexed keywords

PROPAFENONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; SINUS RHYTHM;

EID: 0029966186     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1996.tb03257.x     Document Type: Article

References (23)

1. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects. Am J Cardiol 1994; 74:236.
2. Brand FN, Abbot RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation JAMA 1985; 254:3449.
3. Campbell RWF. Atrial fibrillation: Steering management course between thromboembolism and proarrhythmic risk. Eur Heart J 1995; 16(Suppl. G):28.
4. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992; 116:1.
5. Bianconi M, Boccadamo R, Pappalardo A, et al. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989; 64:335.
6. Capucci A, Boriani G, Rubino I, et al. A controlled study on oral propafenone versus quinidine plus digoxin in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994; 43:305.
7. Antman EM, Beamer AD, Cantillon C, et al. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1988; 12:1005.
8. Falk R. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 1989; 111:107.
9. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, et al. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 1990; 66:755.
10. Crijns HJ, Van Gelder IC, Lie KI. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. Am J Cardiol 1988; 62:1303.
11. Marcus FI. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation. Am J Cardiol 1990; 66:366.
12. Capucci A, Boriani G, Botto GL, et al. Conversion of recent onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994; 74:503.
13. Botto GL, Falcone C, Bonini W, et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: A single blind controlled study. (abstract) Circulation 1993; 88:I-64.
14. Botto GL, Bonini W, Broffoni T, et al. Effect of single loading oral propafenone or digoxin in recent onset atrial fibrillation: Conversion to sinus rhythm and modulation of ventricular rate. A randomized, placebo controlled study. (abstract) J Am Coll Cardiol 1995; 21:66A.
15. Solokow M, Edgar AL. Blood quinidine concentrations as a guide in treatment of cardiac arrhythmias. Circulation 1950; 1:576.
16. Faber TS, Zehender M, Van de Loo A, et al. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four case reports. Clin Cardiol 1994; 17:197.
17. Cramer G. Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. Acta Med Scand 1968; 490(Suppl.):5.
18. Suttorp MJ, Kingma JH, Jessurun ER, et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990; 16: 1722.
19. Weiner HL, McCarthy EA, Pritchett EL. Regular ventricular rhythm in patients with symptomatic paroxysmal atrial fibrillation. J Am Coll Cardiol 1991; 17:1283.
20. Funck-Brentano C, Kroemer HK, Lee JT, et al. Propafenone. N Engl J Med 1990; 322:518.
21. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 1990; 82: 1106.
22. Flaker GC, Black Shear JL, Mc Bride R, et al., on behalf of S.P.A.F. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20:527.
23. Morganroth J. Risk factors for the development of proarrhythmic events. Am J Cardiol 1987; 59:32E.